Brilanestrant (GDC-0810)
Brilanestrant (GDC-0810, ARN-810) is a potent ER-α binder (ER-α, IC50 = 6.1 nM; ER-β, IC50 = 8.8 nM), a full transcriptional antagonist with no agonism and displays good potency and efficacy in ER-α degradation (EC50 = 0.7 nM) and MCF-7 breast cancer cell viability (IC50 = 2.5 nM) assays with good selectivity over other nuclear hormone receptors.
Trivial name | ARN-810 |
Catalog Number | S7855 |
Molecular Formula | C26H20ClFN2O2 |
CAS# | 1365888-06-7 |
Inchi | InChI=1S/C26H20ClFN2O2/c1-2-21(22-10-9-20(28)14-23(22)27)26(18-8-11-24-19(13-18)15-29-30-24)17-6-3-16(4-7-17)5-12-25(31)32/h3-15H,2H2,1H3,(H,29,30)(H,31,32)/b12-5+,26-21+ |
Inchi Key | BURHGPHDEVGCEZ-KJGLQBJMSA-N |
SMILES | CCC(=C(C1=CC=C(C=C1)C=CC(=O)O)C2=CC3=C(C=C2)NN=C3)C4=C(C=C(C=C4)F)Cl |
Size | 5mg |
Supplier Page | http://www.selleckchem.com/products/brilanestrant-gdc-0810-arn-810.html |
Additional Information | https://file.selleck.cn/downloads/struct/gdc-0810-chemical-structure-s7855.gif |